InSphero Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
110
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
13
- Investments
-
3
InSphero General Information
Description
Developer of cell-based assay and scaffold-free organoid, spheroid, and organ-on-a-chip technology designed to provide biologically relevant insights for in vitro testing. The company offers predictive preclinical testing platforms and three-dimensional cell culture technologies for biotechnology and pharmaceutical companies, enabling them to identify drug efficacy and toxic liabilities, reduce development costs, shorten development timelines, and minimize animal testing.
Contact Information
Website
www.insphero.comCorporate Office
- Wagistrasse 27A
- 8952 Schlieren
- Switzerland
Corporate Office
- Wagistrasse 27A
- 8952 Schlieren
- Switzerland
InSphero Timeline
InSphero Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
InSphero Comparisons
Industry
Financing
Details
InSphero Competitors (27)
One of InSphero’s 27 competitors is Frontier Bio, a Venture Capital-Backed company based in Hayward, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Frontier Bio | Venture Capital-Backed | Hayward, CA | ||||
| Aspect Biosystems | Venture Capital-Backed | Vancouver, Canada | ||||
| Ncardia | Venture Capital-Backed | Leiden, Netherlands | ||||
| Hesperos | Venture Capital-Backed | Orlando, FL | ||||
| 28bio | Venture Capital-Backed | New Orleans, LA |
InSphero Patents
InSphero Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4788786-A1 | Device for studying interactions of biological specimen | Pending | 06-Oct-2023 | ||
| WO-2025073379-A1 | Device for studying interactions of biological specimen | Inactive | 06-Oct-2023 | ||
| EP-4608134-A1 | System for freezing and/or vitrifying biological specimen | Pending | 26-Oct-2022 | ||
| US-20260334463-A1 | System for freezing and/or vitrifying biological specimen | Pending | 26-Oct-2022 | ||
| WO-2024089184-A1 | System for freezing and/or vitrifying biological specimen | Inactive | 26-Oct-2022 | A01N1/145 |
InSphero Signals
InSphero Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
InSphero Acquisitions (3)
InSphero’s most recent deal was a Merger/Acquisition with PhenoVista. The deal was made on 20-May-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| PhenoVista | 20-May-2026 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology | ||
| SUN bioscience | 17-Nov-2025 | Merger/Acquisition | Discovery Tools (Healthcare) | ||
| Doppl | 11-Nov-2025 | Merger/Acquisition | Drug Discovery |
InSphero Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| PhenoVista | San Diego, CA | 2014 |
InSphero FAQs
-
When was InSphero founded?
InSphero was founded in 2009.
-
Where is InSphero headquartered?
InSphero is headquartered in Schlieren, Switzerland.
-
What is the size of InSphero?
InSphero has 110 total employees.
-
What industry is InSphero in?
InSphero’s primary industry is Biotechnology.
-
Is InSphero a private or public company?
InSphero is a Private company.
-
What is InSphero’s current revenue?
The current revenue for InSphero is .
-
How much funding has InSphero raised over time?
InSphero has raised $63.4M.
-
Who are InSphero’s investors?
BroadOak Capital Partners, , SICTIC, ZEISS Ventures, and are 5 of 9 investors who have invested in InSphero.
-
Who are InSphero’s competitors?
Frontier Bio, Aspect Biosystems, Ncardia, Hesperos, and 28bio are some of the 27 competitors of InSphero.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process